おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Abbisko Therapeutics
company
About
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $28M
- Industries
- Health Care,Pharmaceutical,Therapeutics
- Founded date
- Apr 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$263M
Abbisko Therapeutics has raised a total of
$263M
in funding over 2 rounds. Their latest funding was raised on
Jan 7, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 7, 2021 | Series D | $123M | 1 | — | — | Detail |
| Mar 25, 2020 | Series C | $70M | 1 | — | — | Detail |
| Mar 21, 2019 | Series B | $42M | 1 | — | — | Detail |
| Feb 7, 2017 | Series A | $28M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Abbisko Therapeutics is funded by 1 investors.
Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lilly Asia Ventures
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
